With a tenth of the population and workforce, they think they are owed half the country’s CPP. This should be a last straw insult. Canada should have its own referendum on kicking Alberta out, land-lock them, stop subsidies and payments, impose its own charges for anything flowing out, sue for all damages from excessive emissions and say good riddance.
The method is: if the #province had not joined #CPP, but instead maintained its own plan (like Quebec), had exactly the same #contributions as it did with CPP, got the same rate of return on #investment as CPP, minus everything paid out of CPP? The reports actually went further and discounted the value of those payouts to get the lower number, even though it's not in the formula.
@cazabon a different interpretation suggests 16% is more realistic, including the potential risks involved. This one doesn’t include trying to take advantage of the rest of Canada.
"One bill — already approved by the [California State] Senate — would force about 5,300 #US corporations earning more than $1 billion and doing business in #California to annually report their global [greenhouse gas] #emissions that contribute to #ClimateChange.
Another bill that won Senate approval would require more than 10,000 companies with revenues exceeding $500 million to detail how climate change poses #FinancialRisks to their [worldwide] #operations."
If these bills pass all the hurdles - and of course it will be taken to court - California will have caused a financial earthquake that will reverberate around the planet.
"Julie Gorte, SVP sustainable investing at Impax Asset Management, says, “What the #investment community is working at doing is pricing #ClimateRisk. We need real assurance by 2030 … If [a company has] higher #emissions, they’re at greater risk and I’m going to need a premium” to own such companies."
"The #JETP model focuses on expanding access to both public and #PrivateFinance to support critical and catalytic #energy system #investment needs. The funds come from a group of international countries called the International Partner Group (IPG) and private financial institutions. "
So the private money is there to beef up the national contributions. (for what returns?)
We have been told for generations that lowering taxes on the rich helps the economy, and that "increased entitlements" are a burden the taxpayer cannot afford.
These are lies. The truth, borne out by history is this:
Programs that help the poor, the working poor and those unable to work, actually benefit the overall economy and are not a net tax burden on the taxpayers. 1/2
The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19.
This mission is more important then ever, which is why I'm thrilled to announce that I've invested into Vamo! A German #Startup offering "Heatpumps as a Service", so people can make the switch without a hefty upfront investment!
Now let's get everyone onto the only low-carbon, affordable and scalable heating system available today. Go #Heatpump!
A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases.
The Nasdaq Biotechnology Index, an indicator of investor sentiment in an industry based on science, continued heading down during the third quarter of 2023.
The US and Kenya announced a trade and investment partnership in July 2022. Talks have been progressing on the way forward in nine areas, including agriculture, anti-corruption, digital trade, environment and climate change action, and workers’ rights and protections.
An alliance of academic labs and venture investors is starting a new research enterprise to speed development of treatments for rare diseases in the U.S. and U.K.
A life science venture investor is merging two of its biotechnology portfolio companies to form a single developer of nanoscale medications with programmable properties.
Photo-shoot today at National Press Club, former congressman and now Amb. Joseph Kennedy III, special envoy to Northern Ireland for economic affairs, talking about U.S. trade with Northern Ireland of all things.
A biotechnology company designing immunotherapies for solid tumor cancers with a patient's white blood cells is raising $80 million in its initial public offering or IPO.
A company spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round.
Venture capital funding for start-ups worldwide continued dropping in the second quarter of 2023 with dollar volumes down by double digits from just the first quarter of the year.
A new company developing treatments for neurological and psychiatric diseases from aberrant immune system activity is raising $58 million in seed funds.
Venture investments in U.S. life science and biotechnology start-ups in the third quarter of 2023 rose from the previous two quarters to reach pre-pandemic levels.
A new company developing digital cardiac diagnostics is collaborating with the Mayo Clinic on early detection of coronary artery disease, a key trigger of heart attacks.